| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −6.2× | −1.8× | |
| Price / Book | 5.2× | 2.1× | |
| Price / Sales | 9.8× | 4.0× | |
| Price / Free cash flow | −6.6× | −1.6× | |
| EV / EBITDA | −6.1× | −1.1× | |
| Earnings yield | −16.0% | −14.0% | |
| Free cash flow yield | −15.0% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,277.67 | −2.22% | $1.2T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $262.80 | −1.80% | $632.64B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.91 | −0.10% | $503.47B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $423.36 | −0.38% | $380.01B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.36 | −1.96% | $356.16B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.83 | −3.48% | $271.79B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $171.21 | −0.79% | $265.53B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $666.57 | −1.47% | $246.46B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $441.88 | −1.21% | $238.89B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.83 | −0.23% | $194.46B | 22.9× | 37.5% | +26.7% |
